Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers (multiple letters) [3]

Journal of the National Cancer Institute

Volumn 95, Issue 13, 2003, Pages 1010-1013

  Hopper, John L ^a   Baron, John A ^b   De Bock, Geertruida ^c   Tollenaar, Rob A E M ^c   Papelard, Hadewych ^c   Vliet Vlieland, Theodora P M ^c   Devilee, Peter ^c   Cornelisse, Cornelis J ^c   Vandenbroucke, Jan P ^c   Rookus, Matti A ^d   Brohet, Richard ^d   van Leeuwen, Flora E ^d   Narod, Steven ^e,f   Ghadirian, Parviz ^e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA; ORAL CONTRACEPTIVE AGENT;

ADULT; BLOOD SAMPLING; BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DRUG USE; FEMALE; GENE MUTATION; GERM LINE; HETEROZYGOTE; HUMAN; INFORMATION PROCESSING; INTERVIEW; LETTER; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL LITERATURE; METHODOLOGY; PATIENT INFORMATION; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE;

EID: 0041807970     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/95.13.1010     Document Type: Letter

References (0)